Debate heating up over reference pricing system

Published: 2002-08-27 07:00:00

Updated: 2002-08-27 07:00:00

A controversy is mounting over whether the government should implement the new drug-pricing system, known as the "reference pricing system (RPS)," in coming September in order to cut the drug charges, since a number of foreign countries have modified or discontinued the RPS due to the increasing ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK